IM Cannabis Corp. (IMCC)
0.591
-0.13
(-17.55%)
USD |
NASDAQ |
Nov 05, 14:10
IM Cannabis Enterprise Value : 20.14M for Nov. 4, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2026 | 20.14M |
| November 03, 2026 | 20.27M |
| November 02, 2026 | 20.66M |
| October 30, 2026 | 21.35M |
| October 29, 2026 | 23.24M |
| October 28, 2026 | 22.73M |
| October 27, 2026 | 22.32M |
| October 26, 2026 | 22.64M |
| October 23, 2026 | 22.77M |
| October 22, 2026 | 23.53M |
| October 21, 2026 | 27.86M |
| October 20, 2026 | 31.28M |
| October 19, 2026 | 32.91M |
| October 16, 2026 | 31.12M |
| October 15, 2026 | 30.14M |
| October 14, 2026 | 30.47M |
| October 13, 2026 | 30.63M |
| October 12, 2026 | 32.26M |
| October 09, 2026 | 34.22M |
| October 08, 2026 | 36.50M |
| October 07, 2026 | 39.43M |
| October 06, 2026 | 40.09M |
| October 05, 2026 | 40.09M |
| October 02, 2026 | 41.72M |
| October 01, 2026 | 43.84M |
| Date | Value |
|---|---|
| September 30, 2026 | 45.14M |
| September 29, 2026 | 48.40M |
| September 28, 2026 | 48.89M |
| September 25, 2026 | 54.76M |
| September 24, 2026 | 60.30M |
| September 23, 2026 | 55.90M |
| September 22, 2026 | 75.95M |
| September 21, 2026 | 58.75M |
| September 18, 2026 | 77.42M |
| September 17, 2026 | 36.83M |
| September 16, 2026 | 35.03M |
| September 15, 2026 | 35.03M |
| September 14, 2026 | 36.50M |
| September 11, 2026 | 36.99M |
| September 10, 2026 | 36.99M |
| September 09, 2026 | 40.90M |
| September 08, 2026 | 40.41M |
| September 04, 2026 | 40.74M |
| September 03, 2026 | 44.32M |
| September 02, 2026 | 57.37M |
| September 01, 2026 | 55.57M |
| August 31, 2026 | 58.34M |
| August 28, 2026 | 64.05M |
| August 27, 2026 | 72.69M |
| August 26, 2026 | 62.94M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| InterCure Ltd. | -- |
| Raphael Pharmaceutical, Inc. | 30.51M |
| Teva Pharmaceutical Industries Ltd. | 61.66B |
| RedHill Biopharma Ltd. | -11.30M |
| MediWound Ltd. | 157.52M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.168M |
| Revenue (Quarterly) | 5.482M |
| Total Expenses (Quarterly) | 8.632M |
| EPS Diluted (Quarterly) | -0.3399 |
| Gross Profit Margin (Quarterly) | 19.83% |
| Profit Margin (Quarterly) | -57.78% |
| Earnings Yield | -354.3% |
| Normalized Earnings Yield | -354.26 |